2000
Repeat Screening for HIV: When to Test and Why
Kaplan E, Satten G. Repeat Screening for HIV: When to Test and Why. JAIDS Journal Of Acquired Immune Deficiency Syndromes 2000, 23: 339-345. DOI: 10.1097/00042560-200004010-00010.Peer-Reviewed Original ResearchRepeat Screening for HIV: When to Test and Why
Kaplan E, Satten G. Repeat Screening for HIV: When to Test and Why. JAIDS Journal Of Acquired Immune Deficiency Syndromes 2000, 23: 339-345. DOI: 10.1097/00126334-200004010-00008.Peer-Reviewed Original Research
1998
A mathematical model of HIV transmission in NSW prisons
Dolan K, Wodak A, Hall W, Kaplan E. A mathematical model of HIV transmission in NSW prisons. Drug And Alcohol Dependence 1998, 50: 197-202. PMID: 9649972, DOI: 10.1016/s0376-8716(98)00009-x.Peer-Reviewed Original Research
1993
Needle exchange decreases the prevalence of HIV-1 proviral DNA in returned syringes in New Haven, Connecticut
Heimer R, Kaplan E, Khoshnood K, Jariwala B, Cadman E. Needle exchange decreases the prevalence of HIV-1 proviral DNA in returned syringes in New Haven, Connecticut. The American Journal Of Medicine 1993, 95: 214-220. PMID: 8356986, DOI: 10.1016/0002-9343(93)90263-o.Peer-Reviewed Original ResearchConceptsHIV-1 proviral DNANeedle exchange programsProviral DNANew Haven's needle exchange programNeedle exchangeHIV-1 prevalenceIntravenous drug usersNeedle exchange clientsDrug treatment programsPercentage of syringesDrug use habitsSyringe trackingDNA prevalenceNew HavenPolymerase chain reactionDrug treatmentDrug usersTreatment programPrevalenceChain reactionExchange programsSyringesMonthsProgram participantsFunded evaluation
1989
What are the Risks of Risky Sex? Modeling the AIDS Epidemic
Kaplan E. What are the Risks of Risky Sex? Modeling the AIDS Epidemic. Operations Research 1989, 37: 198-209. DOI: 10.1287/opre.37.2.198.Peer-Reviewed Original ResearchHIV infectionSex lifeAIDS Cohort StudyEpidemic of AIDSAIDS case ratesArbitrary probability distributionsSex rateCohort studyHIV prevalenceCase ratesAIDSAIDS epidemicInfectionMathematical modelRisky sexProbability distributionEpidemicPrevalenceAIDS modelLife distributionRandom partner selectionGeneral modelSan FranciscoVaccine